FDA Confirms Infant-Meds Recall

Months after drugmakers pulled infant cold remedies from most pharmacy shelves, the FDA warns consumers of their life-threatening side effects

Three months after a group of pharmaceutical companies voluntarily recalled cough and cold medicine for children under the age of 2, the Food & Drug Administration has issued its own public health advisory stating that parents should not give infants over-the-counter products because of possible life-threatening side effects.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.